Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

American Journal of Surgery

Volumn 189, Issue 4, 2005, Pages 425-428

  Sharpe, J Neal ^a   Shively, Eugene H ^b   Polk Jr , Hiram C ^b  

^a SharpCare   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Complicated skin and soft tissue infections; Linezolid; MRSA; Vancomycin

Indexed keywords

LINEZOLID; VANCOMYCIN;

ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; HOSPITALIZATION; HUMAN; LEG AMPUTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTPATIENT; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

EID: 16844377617     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.01.011     Document Type: Article

References (10)

1. R.P. Rennie, R.N. Jones, A.H. Mutnick Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections Report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000) Diagn Microbiol Infect Dis 45 2003 287 293
2. J. Rello, A. Torres, M. Ricart Ventilator-associated pneumonia by Staphylococcus aureus Comparison of methicillin-resistant and methicillin-sensitive episodes Am J Respir Crit Care Med 150 1994 1545 1549
3. V. Fejfarova, A. Jirkovska, J. Skibova Pathogen resistance and other risk factors in the frequency of lower limb amputations in patients with the diabetic foot syndrome [in Czech] Vnitr Lek 48 2002 302 306
4. L.D. Saravolatz, N. Markowitz, L. Arking Methicillin-resistant Staphylococcus aureus Epidemiologic observations during a community-acquired outbreak Ann Intern Med 96 1982 11 16
5. S.M. Swaney, H. Aoki, M.C. Ganoza The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria Antimicrob Agents Chemother 42 1998 3251 3255
6. D.L. Stevens, D. Herr, H. Lampiris Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections Clin Infect Dis 34 2002 1481 1490
7. D.L. Stevens, M.S. Harrison, D.R. Graham Linezolid versus vancomycin for the treatment of suspected or proven methicillin-resistant Staphylococcus species infection Poster presented at the 41st Annual Meeting of the Infectious Diseases Society of America 2003 October 9-12, San Diego, CA (poster 181).
8. J.A. Weigelt, K.M. Itani, W.K. Lau Linezolid vs vancomycin in the treatment of complicated skin and soft tissue infections Clinically significant outcome differences Poster presented at the 41st Annual Meeting of the Infectious Diseases Society of America 2003 October 9-12, San Diego, CA (poster 314).
9. J. Weigelt, K. Itani, J. Li Linezolid reduces LOS when compared to vancomycin for complicated skin and soft tissue infections due to suspected or proven MRSA Results from a randomized trial Presented at the 41st Annual Meeting of the Infectious Diseases Society of America 2003 October 9-12, San Diego, CA (poster 315).
10. J.Z. Li, R.J. Willke, B.E. Rittenhouse Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci Results from a randomized clinical trial Surg Infect (Larchmt) 4 2003 57 70